You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 7, April 14, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Nutrition/ Malnutrition
 •Cardiovascular System
 •Women's Health
 •Women's Health, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

COMMENTS & OPINIONS
Clinical Trials of Antioxidant Supplementation in the Prevention of Cardiovascular Events—Reply

Nancy R. Cook, ScD; Christine M. Albert, MD, MPH; JoAnn E. Manson, MD, DrPH; for the WACS Investigator Group

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We thank Katsiki and Manes for their interest in our study,1 which addresses the role of antioxidant vitamins, alone and in combination, in the prevention of cardiovascular events. Although our trial included only women, several antioxidant trials have been conducted in men or women separately, with similar results.2

We note that we provided information about the menopausal status of the study population in our article; this information is presented in Table 1, with subgroup effects by menopausal status given in Table 3.1

Participants in WACS represent a relatively well-nourished population of female health professionals. Women in the trial were asked to avoid taking supplements above the recommended daily allowance for these agents. The prevalence of multivitamin use at baseline is presented in Table 11 and was similar across randomized . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.